4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-006694
Options or other derivatives
- Chief Financial Officer acquired 650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cook Kevin Leon · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-10 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +650,000 | 650,000 | D |
Loading xslF345X03/ownership.xml…